in patients with type 2 diabetes and obesity have been found (7) . The role of endoplasmic reticulum stress in diabetic kidney disease has been confirmed, as well (8) . (e) Trace elements: Zinc, and chromium have been shown to significantly decrease in blood samples of DN cases compared to healthy subjects (9) .
Management

Angiotensin-converting-enzyme inhibitor (ACE) inhibitors and angiotensin receptor blockers (ARBs)
While earlier studies of combination ACE inhibitor and ARB reported dominance of grouping therapy for lowering albuminuria and blood pressure against either alone (10) . Recent studies have confirmed the combination treatment was associated with higher incidences of acute renal failure and hyperkalemia (11) .
Aldosterone antagonist
Bearing in mind that aldosterone endorses fibrosis, inflammation, and generation of ROS, Spironolactone, as expected, reduces proteinuria (12) .
Hypoglycemic agents
Good glycemic control is effective in reducing diabetic microvascular complications. Besides, DPP-4 inhibitors (gliptins) have shown anti-inflammatory and antiapoptotic properties in diabetic kidney disease. For instance, in type 2 diabetics, sitagliptin treatment for 6 months diminishes albuminuria independent of HbA1c (13) .
